Search by Drug Name or NDC
NDC 51672-1376-06 Naftifine Hydrochloride 20 mg/g Details
Naftifine Hydrochloride 20 mg/g
Naftifine Hydrochloride is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is NAFTIFINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Naftifine is used for skin infections such as athlete's foot, jock itch, and ringworm. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 51672-1376-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Naftifine Topical
Product Information
| NDC | 51672-1376 |
|---|---|
| Product ID | 51672-1376_9ffda8a6-78db-4240-a35f-5f63b0526d16 |
| Associated GPIs | |
| GCN Sequence Number | 071236 |
| GCN Sequence Number Description | naftifine HCl GEL (GRAM) 2 % TOPICAL |
| HIC3 | Q5F |
| HIC3 Description | TOPICAL ANTIFUNGALS |
| GCN | 34933 |
| HICL Sequence Number | 003204 |
| HICL Sequence Number Description | NAFTIFINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Naftifine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Naftifine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/g |
| Substance Name | NAFTIFINE HYDROCHLORIDE |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Pharmaceutical Class | Allylamine Antifungal [EPC], Allylamine [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208201 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51672-1376-06 (51672137606)
| NDC Package Code | 51672-1376-6 |
|---|---|
| Billing NDC | 51672137606 |
| Package | 1 TUBE in 1 CARTON (51672-1376-6) / 45 g in 1 TUBE |
| Marketing Start Date | 2023-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |